title: Treatment of acute central retinal artery occlusionwith the platelet glycoprotein IIb/IIIa receptor inhibitor tirofiban.
authors.forename: Hans
authors.initials: H
authors.lastname: Hölschermann
authors.forename: Cathrin
authors.initials: C
authors.lastname: Krombach
authors.forename: Anette
authors.initials: A
authors.lastname: Jung
authors.forename: Felix
authors.initials: F
authors.lastname: Jacobi
authors.forename: Harald
authors.initials: H
authors.lastname: Tillmanns
authors.forename: Frank
authors.initials: F
authors.lastname: Weinand
mesh_terms: D000368:Aged; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D010975:Platelet Aggregation Inhibitors / Q000627:therapeutic use*; D019039:Platelet Glycoprotein GPIIb-IIIa Complex / Q000037:antagonists & inhibitors*; D015356:Retinal Artery Occlusion / Q000188:drug therapy*; D000077466:Tirofiban; D016896:Treatment Outcome; D014443:Tyrosine / Q000031:analogs & derivatives* / Q000627:therapeutic use; D014792:Visual Acuity
chemical_list: D010975:Platelet Aggregation Inhibitors; D019039:Platelet Glycoprotein GPIIb-IIIa Complex; D014443:Tyrosine; D000077466:Tirofiban